
Medtronic PLC Stock Underperforms Tuesday When Compared To Competitors

I'm PortAI, I can summarize articles.
Medtronic PLC's stock fell 1.62% to $99.62 on Tuesday, marking its third consecutive day of losses. It underperformed compared to competitors like Johnson & Johnson, Danaher Corp., and Abbott Laboratories. The stock is 6.31% below its 52-week high. Trading volume was 2.3 million below the 50-day average. The S&P 500 and Dow Jones also saw declines.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

